Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements

6Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Siddiqui, M., Konoplev, S., Issa, G., Kantarjian, H., Daver, N., Ravandi, F., … Hasserjian, R. P. (2023, April 1). Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American Journal of Hematology. John Wiley and Sons Inc. https://doi.org/10.1002/ajh.26858

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free